تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

سعر ترينتوكسيمال Trentoximal‏ 20مجم/مل 5 امبول 100 مجم per ampoule 2026

Trentoximal

دواعي استعمال ترينتوكسيمال

  • Peripheral vascular diseaseالفئة: AdultsHealth Products Regulatory Authority (HPRA), Ireland
  • Cerebrovascular insufficiency (increase in cerebral blood flow not necessarily accompanied by clinical improvement)الفئة: AdultsHealth Products Regulatory Authority (HPRA), Ireland
  • Peripheral vascular diseasePopulation: AdultsHealth Products Regulatory Authority (HPRA), Ireland
  • Cerebrovascular insufficiency (increase in cerebral blood flow not necessarily accompanied by clinical improvement)Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland

معلومات الدواء

التفاصيل الكاملة
عن الدواءAbout the medicine

Trentoximal ampoules containing pentoxifylline 100 mg (20 mg/ml per Arabic name), an anti-ischaemic haemorheologic agent, marketed in Egypt (Alexandria > Egypharma-Egypt).

Trentoximal ampoules containing pentoxifylline 100 mg (20 mg/ml per Arabic name), an anti-ischaemic haemorheologic agent, marketed in Egypt (Alexandria > Egypharma-Egypt).

موانع الاستعمالContraindications
  • Hypersensitivity to pentoxifylline or other methylxanthines; cerebral haemorrhage; extensive retinal haemorrhage; acute myocardial infarction.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
  • Hypersensitivity to pentoxifylline or other methylxanthines; cerebral haemorrhage; extensive retinal haemorrhage; acute myocardial infarction.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
تحذيرات واحتياطاتWarnings & precautions
  • Careful monitoring in severe cardiac arrhythmias, myocardial infarction, diabetes mellitus and increased bleeding tendency; caution in hypotension or severe coronary artery disease (transient hypotension may reduce coronary perfusion).نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
  • Careful monitoring in severe cardiac arrhythmias, myocardial infarction, diabetes mellitus and increased bleeding tendency; caution in hypotension or severe coronary artery disease (transient hypotension may reduce coronary perfusion).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
التداخلات الدوائيةDrug interactions
  • Insulin and oral antidiabetic agentsMay enhance hypoglycaemic effect (increased insulin release); insulin dose reduction occasionally needed.Health Products Regulatory Authority (HPRA), Ireland
  • Antihypertensive agentsMay potentiate antihypertensive effect; dose reduction of the antihypertensive may be needed.Health Products Regulatory Authority (HPRA), Ireland
  • TheophyllineMay increase theophylline levels in some patients.Health Products Regulatory Authority (HPRA), Ireland
عرض الكل (4)
  • Insulin and oral antidiabetic agentsMay enhance hypoglycaemic effect (increased insulin release); insulin dose reduction occasionally needed.Health Products Regulatory Authority (HPRA), Ireland
  • Antihypertensive agentsMay potentiate antihypertensive effect; dose reduction of the antihypertensive may be needed.Health Products Regulatory Authority (HPRA), Ireland
  • TheophyllineMay increase theophylline levels in some patients.Health Products Regulatory Authority (HPRA), Ireland
Show all (4)
الحمل والرضاعةPregnancy & breastfeeding
  • Use in pregnancy is contraindicated (Irish SmPC).نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
  • Should not be used in women breastfeeding infants (Irish SmPC).نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA), Ireland
  • Use in pregnancy is contraindicated (Irish SmPC).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
  • Should not be used in women breastfeeding infants (Irish SmPC).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

تابع أسعار الأدوية أول بأول

بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص

تاريخ السعر

تغيّر السعر الرسمي

تغيّر السعر الرسمي: من 26.25 إلى 35 ج.م، 2 أسعار مسجلة

تغيّر السعر الرسمي
التاريخالسعر (ج.م)
سعر سابق بدون تاريخ26.25
35
تغييرات السعر السابقة
التاريخمنإلىالتغيير
26.25ج.م35ج.مزيادة 33.3%

المعرّفات

مراجع علمية للمادة الفعالة

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.